UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036494
Receipt number R000041582
Scientific Title Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease
Date of disclosure of the study information 2019/05/01
Last modified on 2021/10/14 09:18:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease

Acronym

Effect of gastric acid on concentration of levodopa preparations in Parkinson's disease

Scientific Title

Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease

Scientific Title:Acronym

Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the relationship between gastric acid and levodopa pereparations.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concentration of levodopa preparations

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Discontinuance of taking medicine affecting gastric acid for 14 days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with Parkinson's disease who take medicine affecting gastric pH

Key exclusion criteria

1. Patients with a history of gastrointestinal ulcers

2. Patients judged inappropriate with other reasons by investigators

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Noriyuki
Middle name
Last name Miyaue

Organization

Saiseikai Matsuyama Hospital

Division name

Department of Neurology

Zip code

791-8026

Address

880-2, Yamanishi, Matsuyama, Ehime

TEL

089-951-6111

Email

miyaue@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name Noriyuki
Middle name
Last name MIyaue

Organization

Saiseikai Matsuyama Hospital

Division name

Department of Neurology

Zip code

791-8026

Address

880-2, Yamanishi, Matsuyama, Ehime

TEL

089-951-6111

Homepage URL


Email

miyaue@m.ehime-u.ac.jp


Sponsor or person

Institute

Saiseikai Matsuyama Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saiseikai Matsuyama Hospital

Address

880-2, Yamanishi, Matsuyama, Ehime

Tel

089-960-5095

Email

soumu@matsuyama.saiseikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB

2019 Year 03 Month 11 Day

Anticipated trial start date

2019 Year 04 Month 15 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 04 Month 13 Day

Last modified on

2021 Year 10 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041582


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name